United States · Wires & real time · Bloomberg

Novo CEO Doustdar 'Very Optimistic' About CagriSema

Published by Bloomberg · United States 2 h ago

Novo Nordisk A/S Chief Executive Officer Mike Doustdar discusses the possible launch of a new obesity drug called CagriSema. "We are hopeful that we will be able to get the timely…

Read the full article on Bloomberg Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bloomberg.com)

Also worth reading

PR Newswire

Energy Fuels Announces Appointment of Jeffrey Olsen to Board of Directors

Associated Press (Business)

Brazil summons Argentina’s representative after Bolsonaro flees to the US via Argentina

Dow Jones Newswires

Rethinking AI in Enterprise Intelligence

MT Newswires